nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers
|
Laitman, Yael |
|
2015 |
150 |
3 |
p. 631-635 |
artikel |
2 |
CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer
|
Conley, Sarah J. |
|
2015 |
150 |
3 |
p. 559-567 |
artikel |
3 |
Diagnostic accuracy of sentinel node identification is maintained with the addition of local lidocaine and subareolar radioactive colloid injection
|
Stearns, Vered |
|
2015 |
150 |
3 |
p. 589-595 |
artikel |
4 |
Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells
|
Shah, Manisha H. |
|
2015 |
150 |
3 |
p. 523-534 |
artikel |
5 |
Erratum to: Platinum-based chemotherapy in triple-negative advanced breast cancer
|
Villarreal-Garza, Cynthia |
|
2015 |
150 |
3 |
p. 697 |
artikel |
6 |
Erratum to: Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history
|
Kang, Peter Choon Eng |
|
2015 |
150 |
3 |
p. 699-700 |
artikel |
7 |
Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer
|
Zhu, X. |
|
2015 |
150 |
3 |
p. 479-486 |
artikel |
8 |
Impact of breast cancer subtypes and patterns of metastasis on outcome
|
Kast, Karin |
|
2015 |
150 |
3 |
p. 621-629 |
artikel |
9 |
miR-153 inhibits epithelial–mesenchymal transition by targeting metadherin in human breast cancer
|
Li, Wentong |
|
2015 |
150 |
3 |
p. 501-509 |
artikel |
10 |
Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk
|
Wang, Yadong |
|
2015 |
150 |
3 |
p. 467-471 |
artikel |
11 |
Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells
|
Krishnan, Samaya R. |
|
2015 |
150 |
3 |
p. 487-499 |
artikel |
12 |
Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium
|
Bandera, Elisa V. |
|
2015 |
150 |
3 |
p. 655-666 |
artikel |
13 |
Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome
|
Raphael, Jacques |
|
2015 |
150 |
3 |
p. 473-478 |
artikel |
14 |
PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers
|
Stanley, Jennifer |
|
2015 |
150 |
3 |
p. 569-579 |
artikel |
15 |
Personality and breast cancer risk and survival: the Miyagi Cohort Study
|
Minami, Yuko |
|
2015 |
150 |
3 |
p. 675-684 |
artikel |
16 |
Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry
|
Snyder, C. |
|
2015 |
150 |
3 |
p. 637-641 |
artikel |
17 |
Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer
|
Abduljabbar, Rezvan |
|
2015 |
150 |
3 |
p. 511-522 |
artikel |
18 |
Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer
|
Lohmann, Ana Elisa |
|
2015 |
150 |
3 |
p. 605-611 |
artikel |
19 |
Quantitative assessment of HER2 amplification in HER2-positive breast cancer: its association with clinical outcomes
|
Xuan, Qijia |
|
2015 |
150 |
3 |
p. 581-588 |
artikel |
20 |
Race, response to chemotherapy, and outcome within clinical breast cancer subtypes
|
Tichy, J. R. |
|
2015 |
150 |
3 |
p. 667-674 |
artikel |
21 |
Retrospective analysis of metastatic behaviour of breast cancer subtypes
|
Savci-Heijink, C. Dilara |
|
2015 |
150 |
3 |
p. 547-557 |
artikel |
22 |
Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women
|
Rosner, Bernard |
|
2015 |
150 |
3 |
p. 643-653 |
artikel |
23 |
Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer
|
Gernapudi, Ramkishore |
|
2015 |
150 |
3 |
p. 685-695 |
artikel |
24 |
Targeting thyroid hormone receptor beta in triple-negative breast cancer
|
Gu, Guowei |
|
2015 |
150 |
3 |
p. 535-545 |
artikel |
25 |
The association between diabetes and breast cancer stage at diagnosis: a population-based study
|
Lipscombe, Lorraine L. |
|
2015 |
150 |
3 |
p. 613-620 |
artikel |
26 |
The effect of YOCAS©® yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy
|
Peppone, Luke J. |
|
2015 |
150 |
3 |
p. 597-604 |
artikel |